Patents by Inventor Philippe DELANNOY

Philippe DELANNOY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF CASD1 AS A BIOMARKER OF A CANCER EXPRESSING THE O-ACETYLATED-GD2 GANGLIOSIDE
    Publication number: 20240142457
    Abstract: The use of CASD1 as a biomarker of a cancer expressing the O-acetylated-GD2 ganglioside. Also, a method of diagnosing a cancer expressing the O-acetylated-GD2 ganglioside, a method of selecting a subject suffering from a cancer expressing the O-acetylated-GD2 ganglioside for treatment targeting the cancer, or a method of monitoring the response of a subject suffering from a cancer expressing the O-acetylated-GD2 ganglioside to a treatment targeting the cancer.
    Type: Application
    Filed: June 10, 2022
    Publication date: May 2, 2024
    Applicants: OGD2 PHARMA, UNIVERSITE DE LILLE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Sophie GROUX-DEGROOTE, Philippe DELANNOY, Sumeyye CAVDARLI, Jean-Marc LE DOUSSAL, Angélina KASPROWICZ